Literature DB >> 18439107

COL4A3 founder mutations in Greek-Cypriot families with thin basement membrane nephropathy and focal segmental glomerulosclerosis dating from around 18th century.

Konstantinos Voskarides1, Charalampos Patsias, Alkis Pierides, Constantinos Deltas.   

Abstract

Mutations in the COL4A3/COL4A4 genes of type IV collagen account for about 40% of cases of thin basement membrane nephropathy, a condition that is estimated to affect 1% or more of the general population. We recently described 10 Cypriot families with familial hematuria and thin basement membrane nephropathy in the presence of focal segmental glomerulosclerosis, with founder mutations on COL4A3 gene. Seven of the families carried mutation G1334E on haplotype K, and another three carried mutation G871C on haplotype Ky. In this report we performed extension of the haplotypes with additional polymorphic markers, 12 for haplotype K and 22 for haplotype Ky, to estimate the linkage disequilibrium value between the mutation and flanking noncommon markers. Haplotype Ky extended to 13.71 Mb, but we did not attempt further analysis owing to the small number of chromosomes. Haplotype K extended to 3.83 Mb, thereby suggesting that it was a much older event compared to mutation G871C. Mutation G1334E was calculated to be about 5-10 generations old with a possible origin between 1693 and 1818 AD, during the Ottoman ruling of the island. Both mutations are clustered in specific geographic regions with apparently formerly isolated populations, although mutation G1334E has been detected elsewhere on the island. The identification of founder mutations in large families with microscopic hematuria greatly facilitates presymptomatic diagnosis and provides useful information on the history of the population, while it may also assist in association studies in search for disease modifier genes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18439107     DOI: 10.1089/gte.2007.0110

Source DB:  PubMed          Journal:  Genet Test        ISSN: 1090-6576


  10 in total

1.  Autosomal Recessive Alport Syndrome Unveiled by Pregnancy.

Authors:  Erika R Drury; Isaac E Stillman; Martin R Pollak; Bradley M Denker
Journal:  Nephron       Date:  2019-08-13       Impact factor: 2.847

2.  Association of polymorphisms of CYP11B2 gene -344C/T and ACE gene I/D with antihypertensive response to angiotensin receptor blockers in Chinese with hypertension.

Authors:  Hongtao Gong; Liying Mu; Tong Zhang; Xiuying Xu; Fenghe Du
Journal:  J Genet       Date:  2019-03       Impact factor: 1.166

3.  COL4A3/COL4A4 mutations and features in individuals with autosomal recessive Alport syndrome.

Authors:  Helen Storey; Judy Savige; Vanessa Sivakumar; Stephen Abbs; Frances A Flinter
Journal:  J Am Soc Nephrol       Date:  2013-09-19       Impact factor: 10.121

4.  Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees.

Authors:  Yiannis Athanasiou; Konstantinos Voskarides; Daniel P Gale; Loukas Damianou; Charalambos Patsias; Michalis Zavros; Patrick H Maxwell; H Terence Cook; Panayiota Demosthenous; Andreas Hadjisavvas; Kyriacos Kyriacou; Ioanna Zouvani; Alkis Pierides; Constantinos Deltas
Journal:  Clin J Am Soc Nephrol       Date:  2011-05-12       Impact factor: 8.237

Review 5.  Expert consensus guidelines for the genetic diagnosis of Alport syndrome.

Authors:  Judy Savige; Francesca Ariani; Francesca Mari; Mirella Bruttini; Alessandra Renieri; Oliver Gross; Constantinos Deltas; Frances Flinter; Jie Ding; Daniel P Gale; Mato Nagel; Michael Yau; Lev Shagam; Roser Torra; Elisabet Ars; Julia Hoefele; Guido Garosi; Helen Storey
Journal:  Pediatr Nephrol       Date:  2018-07-09       Impact factor: 3.714

6.  Loss of the collagen IV modifier prolyl 3-hydroxylase 2 causes thin basement membrane nephropathy.

Authors:  Hande Aypek; Christoph Krisp; Shun Lu; Shuya Liu; Dominik Kylies; Oliver Kretz; Guochao Wu; Manuela Moritz; Kerstin Amann; Kerstin Benz; Ping Tong; Zheng-Mao Hu; Sulaiman M Alsulaiman; Arif O Khan; Maik Grohmann; Timo Wagner; Janina Müller-Deile; Hartmut Schlüter; Victor G Puelles; Carsten Bergmann; Tobias B Huber; Florian Grahammer
Journal:  J Clin Invest       Date:  2022-05-02       Impact factor: 19.456

7.  Gene spectrum analysis of thalassemia for people residing in northern China.

Authors:  Zhuo Yang; Wenzhe Zhou; Quexuan Cui; Ling Qiu; Bing Han
Journal:  BMC Med Genet       Date:  2019-05-22       Impact factor: 2.103

8.  Genotype-phenotype correlation and prognostic impact in Chinese patients with Alport Syndrome.

Authors:  Shunlai Shang; Fei Peng; Tao Wang; Xiaoyuan Wu; Ping Li; Qinggang Li; Xiang M Chen
Journal:  Mol Genet Genomic Med       Date:  2019-05-29       Impact factor: 2.183

9.  Multiple endocrine neoplasia 2 in Cyprus: evidence for a founder effect.

Authors:  P Fanis; N Skordis; S Frangos; G Christopoulos; E Spanou-Aristidou; E Andreou; P Manoli; M Mavrommatis; S Nicolaou; M Kleanthous; M A Cariolou; V Christophidou-Anastasiadou; G A Tanteles; L A Phylactou; V Neocleous
Journal:  J Endocrinol Invest       Date:  2018-02-02       Impact factor: 4.256

10.  Thin basement membrane nephropathy: is there genetic predisposition to more severe disease?

Authors:  Constantinos Deltas
Journal:  Pediatr Nephrol       Date:  2008-11-19       Impact factor: 3.714

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.